MAVENIR
20.2.2024 08:01:34 CET | Business Wire | Press release
Mavenir, the Network Software Provider building the future of networks, announces new developments on its OpenBeam™ massive MIMO (mMIMO) portfolio, powered by Qualcomm® QRU100 5G RAN platform, in continuation to previous years product launch update. Mavenir expands the OpenBeam™ portfolio by introducing the low-power next-generation 32TRX mMIMO variant along with a high-power 32TRX AAU.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240219034877/en/
Mavenir OpenBeam massive MIMO 32TRX Active Antenna Unit. (Photo: Business Wire)
These next-generation mMIMO 32TRX Active Antenna Units (AAUs) introduce a new breed of open and interoperable radios that are green by design. OpenBeam™ mMIMO AAU delivers exceptional energy efficiency – resulting in one of the leanest mMIMO AAU footprints in the industry, offering substantial OpEx savings.
In addition to the current O-RAN 7.2b specification, the products are also engineered to support ULPI (Uplink Performance Improvement), allowing network operators to improve uplink performance of massive MIMO, minimize latency, and reduce fronthaul bandwidth, especially in urban settings where network capacity demand is high.
The portfolio consists of two discrete models that accelerate 5G mid-band rollouts:
- 32TRX AAU low power model: Offering one of the lowest footprints in the industry, the low power mMIMO AAU delivers 200W output power with 128 antenna elements at the lowest energy consumption. The solution is optimized for deployment in dense environments, driving faster installations and lower operational overheads.
- 32TRX AAU high power model: Mavenir’s high-performance mMIMO AAU capable of delivering 320W output power and offering 192 antenna elements. This platform supports larger instantaneous bandwidth, while the output power extends coverage, making it ideal for RAN sharing deployments.
The 32TRX AAU solutions deliver advanced energy-saving capabilities incorporating smart sleep-mode schemes that are activated during idle, low, and busy hour traffic. These automated capabilities can be further enhanced using AI/ML-based intelligence.
Paco Martin, Head of Open RAN at Vodafone Group: “We are pleased to see the broadening of Mavenir’s mMIMO portfolio with the addition of a low power, compact product fitting our single-operator and footprint-constrained sites, on top of the existing higher power leading solution. Further adoption of Qualcomm QRU100 5G RAN Platform keeps bringing high performance and power efficient Open RAN radios allowing us to deliver the best customer experience.”
BG Kumar, President, Access Networks, Platforms and MDE from Mavenir said: “With this continuing evolution and enhancement of our OpenBeam™ massive MIMO radio solutions, Mavenir is once again setting new standards in the industry for energy efficiency, sustainability and performance.”
“We are very pleased with this extension to Mavenir’s portfolio of high performing and power efficient Massive MIMO Radios, powered by Qualcomm QRU100 5G RAN Platform,” said Gerardo Giaretta, Vice President, Product Management, Qualcomm Technologies, Inc. “This is another great milestone in our ongoing collaboration with Mavenir, driving full-scale adoption of Open and Virtualized RAN.”
Mavenir’s OpenBeam™ full radio portfolio will be displayed at the upcoming Mobile World Congress in Barcelona, Feb 26-29, in Hall 2 Stand 2H60. For more on Mavenir’s presence at the show visit www.mavenir.com/mwc-2024
About Mavenir
Mavenir is building the future of networks and pioneering advanced technology, focusing on the vision of a single, software-based automated network that runs on any cloud. As the industry’s only end-to-end, cloud-native network software provider, Mavenir is focused on transforming the way the world connects, accelerating software network transformation for 300+ Communications Service Providers and Enterprises in over 120 countries, which serve more than 50% of the world’s subscribers.
For more information, please visit www.mavenir.com
Qualcomm is a trademark or registered trademark of Qualcomm Incorporated.
Qualcomm branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240219034877/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ThetaRay Named World’s Best Software Provider for AML and Sanctions Screening in the 2026 Euromoney Transaction Banking Awards5.11.2026 19:30:00 CET | Press release
Recognition caps standout year alongside ThetaRay’s Top 10 (#8) ranking in the 2026 Chartis Financial Crime and Compliance50 (FCC50) and category win for Explainable AI. ThetaRay, a global leader in AI-native financial crime compliance infrastructure, has been named The World’s Best Software Provider for AML and Sanctions Screening at the 2026 Euromoney Transaction Banking Awards. Evaluated by Euromoney’s editorial and research team, ThetaRay was recognized for technology excellence, verifiable performance, and advancing the modern transaction banking value chain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105714764/en/ The recognition reinforces ThetaRay’s standing as foundational compliance infrastructure for global institutions, closely following Chartis Research ranking ThetaRay #8 globally in the Financial Crime and Compliance50 (FCC50) 2026 report and naming the company a Category Winner for Explainable AI. “Our
Arthur D. Little: H1 2026 Private Capital Fundraising Strengthens While Market Sentiment Highlights Investor Shift to Europe over US and Asia5.11.2026 18:58:00 CET | Press release
H1 fundraising up 6% year-on-year as 43% of LPs see geopolitical volatility favouring European funds AI usage dominates industry attention, defence leads target investment themes Invest Europe, the association representing Europe’s private equity, venture capital and infrastructure sectors, as well as their investors, today released ‘Investing in Europe: Private Equity Activity H1 2026’ and ‘The Insight: State of the European Private Equity Industry 2026’, an annual market sentiment report published jointly with global management consultancy Arthur D. Little (ADL). Together, these show increased fundraising for European private equity and venture capital versus the same period last year, stronger investor allocation expectations for Europe, and declining appetite for the US and Asia. The sentiment report also demonstrates how AI is reshaping the industry and portfolio companies, while defence-related themes are topping GPs’ target investments. GPs (General Partners/fund managers of PE
Angelalign Appoints Marco Gadola as Senior Advisor5.11.2026 18:35:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel”) http://www.angelaligner.com, a global clear aligner leader, today announced that Marco Gadola has joined Angel as Senior Advisor. In this role, Marco will advise the Board and senior management on culture, strategy and governance. Marco, who has held many leadership positions, is well-known as a former CEO of Straumann Group, a leading global medical device company focused on dentistry. Marco said he is excited to join Angel. “I’ve followed Angel for 10 years and have seen how it has evolved,” he said, “It’s grown from a regional leader in innovative clinical solutions and high-quality products, to a worldwide organization trusted by orthodontic specialists, with an impressive innovation pipeline.” Fox Hu, CEO of Angel, said: “Angel has strong core capabilities, but we must continue to improve to serve orthodontists even better. We welcome Marco as an advocate for our customers and employees around the world and to help us build an outstan
Boomi Named a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms5.11.2026 17:25:00 CET | Press release
Boomi governs agents, with flexibility across cloud, hybrid, and fully on-premises deployments behind the firewall. Boomi, the data activation company for AI, today announced it has been recognized as a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms. Boomi delivers agent management capabilities through the Agent Control Plane. Boomi believes this placement reflects its approach to solving one of the biggest hurdles in turning AI into ROI, by providing critical AI infrastructure that connects, governs, and controls AI costs across agents and skills from native and third-party providers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105515847/en/ Boomi Named a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms Key Takeaways Boomi has been recognized as a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms. A complimentary copy of t
Biocodex Invests €15 Million in a New Industrial Platform for Live Biotherapeutic Products5.11.2026 16:04:00 CET | Press release
Biocodex, an independent French pharmaceutical company, announces a €15 million investment to develop an industrial platform in Beauvais, France, dedicated to Live Biotherapeutic Products (LBPs) derived from the microbiome. Building on more than 70 years of expertise in living microorganisms, microbiota, fermentation and pharmaceutical manufacturing, Biocodex aims to support its partners and, ultimately, its own programs, from research through to clinical and commercial production. The project aims to strengthen healthcare and industrial sovereignty in the field of next-generation microbiome-based therapies. Scientific advances in microbiome science are opening up new therapeutic perspectives, notably in oncology, inflammatory bowel diseases, certain rare diseases and women’s health. Moving from research to pharmaceutical production requires facilities adapted to living microorganisms and pharmaceutical requirements. Open to biotechnology companies worldwide, it will support LBP progra
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
